tiprankstipranks
Allarity Therapeutics Maintains NASDAQ Compliance with Bid Price
Company Announcements

Allarity Therapeutics Maintains NASDAQ Compliance with Bid Price

Pick the best stocks and maximize your portfolio:

An update from Allarity Therapeutics, Inc. (ALLR) is now available.

Allarity Therapeutics, Inc. has announced that they have successfully met NASDAQ’s Minimum Bid Price Requirement, ensuring their continued compliance with the stock market’s standards. This development, which is significant for the company’s financial health and investor confidence, has been officially shared in a press release but is not considered filed for legal purposes unless expressly stated in future documents.

Learn more about ALLR stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAllarity reports progress in Phase 2 stenoparib trial
TheFlyAllarity reports Q3 EPS ($7.71)
TheFlyAllarity granted EPO for DRP companion diagnostic for stenoparib
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App